Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
Abstract Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking targeted therapy currently. Recent studies imply that protein kinase C may play important roles in TNBC development and could be a specific target. In this study, we evaluated the anti-proliferative activity of PKC i...
Saved in:
Main Authors: | Wanjun Lin, Jiajun Huang, Zhongwen Yuan, Senling Feng, Ying Xie, Wenzhe Ma |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/30a9236ffdf242609ca8aa3c42f629d8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
by: Ivana Zagorac, et al.
Published: (2018) -
Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
by: Swanner J, et al.
Published: (2015) -
A triple negative breast cancer: what it is not!
by: Katakkar SB
Published: (2012) -
Triple negative breast cancer: an Indian perspective
by: Akhtar M, et al.
Published: (2015) -
Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
by: Wen-Hung Kuo, et al.
Published: (2012)